Searchable abstracts of presentations at key conferences in endocrinology

ea0035p1134 | Thyroid Cancer | ECE2014

Papillary thyroid microcarcinoma: focus on prevalence, characterization and follow-up during a 10 years time period

Pereira Maria Teresa , Carvalho Andre , Garrido Susana , Caldas Ana Rita , Freitas Claudia , Teixeira Sofia , Valente Vitor , Canha Antonio , Costa Moreira , Bateira Paulo , Borges Fatima

Introduction: Recent studies point to an ever increasing papillary thyroid microcarcinoma (PTMC) prevalence, with a percentage range between 20 and 43% of all differentiated thyroid carcinomas. It is many times considered an ‘incidental’ finding and its clinical behaviour is uncertain.Aims: To characterize a cohort of patients with PTMC, with reference to clinical and pathological variables and outcome.Methods: Data from ...

ea0035p1136 | Thyroid Cancer | ECE2014

Prevalence and risk of malignancy of thyroid incidentalomas discovered by 18F-fluorodeoxyglucose positron emission tomography

da Silva Tiago Nunes , Luiz Henrique Vara , Pereira Bernardo Dias , Matos Ana Catarina , Manita Isabel , Carmona Susana , Santos Ana Isabel , Portugal Jorge

The use of 18F-fluorodeoxyglucose positron emission tomography (18F-FDG–PET) has increased the detection of thyroid incidentalomas (TI). These are associated with a risk of malignancy between 25 and 50%. Some studies show an association between SUVmax uptake and malignancy.The objective of this study was to determine the prevalence of malignancy on 18F-FDG–PET positive thyroid nodules and to evaluate the relatio...

ea0070aep427 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Relationship between blastocystis sp. parasitization and metabolic syndrome in an obese spanish population

Caudet-Esteban. Jana , Cifre Martinez Susana , Trelis Villanueva María , Camara-Gómez Rosa , Palasí Rosana , Merino Torres Juan Francisco

Introduction: Blastocystissp. (BS) is the most common intestinal parasite that is isolated in human fecal samples. Its pathogenic role is still questioned. While some consider it a beneficial component of the human intestinal microbiota, some evidence relates it with dysbiosis and development of metabolic syndrome (MS). Its presence has been inversely correlated with BMI.Objective: The objective of this study is two-fold: determining the prevale...

ea0070aep672 | Pituitary and Neuroendocrinology | ECE2020

Giant prolactinomas: Is it possible to stop treatment?

Mallea-Gil Susana , Diez Sabrina , Tubert Gloria , Cuccia Mariela , Rodriguez Noelia , Stalldecker Graciela , de los Angeles Sosa Maria , Peressotti Bruno , Palazzo Adriana , Ballarino Carolina

Giant prolactinomas are tumors with a large size >4 cm and/or prolactin levels higher than 3000 ng/ml and/or highly invasive growth. Today dopamine agonists (DA), mainly cabergoline (CAB), are the first-line choice in the treatment of these tumorsTo assess the efficacy, safety and long-term follow-up of patients with giant prolactinomas treated with DA. We retrospectively reviewed the clinical records of 33 patients with giant prolactinomas. Mea...

ea0070ep4 | Adrenal and Cardiovascular Endocrinology | ECE2020

Ectopic cushing syndrome: A cases-series in a tertiary centre in Spain

Gonzalez Fernandez Laura , Brox Torrecilla Noemi , Miguelez Gonzalez Maria , Atencia Goñi Jose , Weber Bettina , Munoz Diego , Carlos Percovich Juan , Monereo Megias Susana , García Centeno Rogelio

Introduction: Ectopic Cushing Syndrome (ECS) is a rare disease associated with significant comorbidity. Among the causes of Cushing’s syndrome (CS), ACTH-producing extrahypophyseal tumours are rarely reported. The aim of our study is to describe the clinical, diagnostic and therapeutic characteristics of patients with ECS treated in our Endocrinology department over a 15-year period.Methods: A cross-sectional unicentric retrospective study was desi...

ea0022p506 | Growth factors | ECE2010

Testicular TGF-β1 system expression and its participation in hypertrophy and hyperplasia of Leydig cells

Gonzalez Candela Rocio , Gonzalez Betina , Rulli Susana , Franca Luiz Renato , Costa Guillermi Mattos Jardim , Huhtaniemi Ilpo , Calandra Ricardo Saul , Gonzalez-Calvar Silvia Ines

Transforming growth factor β1 has a critical role in the regulation of testicular function. Transgenic male mice over expressing α and β subunits of hCG (hCG+) are infertile and testicular steroidogenesis is enhanced showing high levels of testosterone and progesterone (P4). The chronic hCG hyperstimulation leads to Leydig cell (LC) hypertrophy/hyperplasia in prepubertal mice.Aims: To analyze: i) the expression of the TGF-β...

ea0011p893 | Thyroid | ECE2006

Cytostatic effect of plitidepsin (AplidinTM) in human undifferentiated (anaplastic) thyroid carcinoma

Bravo Susana , garcia-renduelles Maria , Seoane Rafael , Dosil Vanesa , Cameselle Jose , Lopez-Lázaro Luis , Zalvide Juan , Barreiro Franci , Pombo Celia , Alvarez Clara

Undifferentiated thyroid carcinoma is a highly aggressive human cancer with poor prognosis. A strong association has been observed between undifferentiated thyroid carcinoma and TP53 mutations. Plitidepsin (AplidinTM) a novel anticancer compound from a sea tunicate, has been reported to induce apoptosis independently of TP53 status. We investigated the actions of plitidepsin in human thyroid cancer cells. initiallyexperiments using primary cultured cells from a d...

ea0056p138 | Endocrine tumours and neoplasia | ECE2018

Evaluation of neurofibromatosis type 1 and gastroenteropancreatic neuroendocrine tumors.

Percovich Juan Carlos , Atencia Jose , Garcia Rogelio , Sambo Marcel , Blanco Montserrat , Rotger Amanda , Lopez Dolores , Olmedilla Yoko , Picallo Maria , Velez Marian , Agreda Javier , Brox Noemi , Monereo Susana

Introduction: Neurofibromatosis type 1 (NF1) is an autosomal dominant condition with an incidence of 1 in 2600 to 3000 individuals. Patients with this disorder are characterized by multiple neurofibromas, caf-au-lait macules, axillary freckling, optic gliomas, iris hamartomas, and skeletal abnormalities. Overall risk of developing neoplasms is approximately 2 to 4-fold higher in patients with NF1, with a risk of malignancy estimated between 5 and 15%. Endocrinopathies are some...

ea0056p1142 | Thyroid cancer | ECE2018

Increased incidence of thyroid cancer in a spanish tertiary hospital, valladolid, spain: evolution and clinical characteristics, 2002–2016

Calvo Susana Garcia , Diaz-Soto Gonzalo , Sanz Maria Alvarez-Quinones , Martinez-Pino Isabel , Torres Beatriz , Lopez Juan Jose , Mateos Juan Jose , Luis Daniel de

Introduction: Thyroid cancer is the most frequent malignant endocrine neoplasia. Its incidence has significantly risen worldwide in the last decades.Objective: To estimate the incidence of thyroid cancer in Valladolid’s east area population, Spain, over the period 2002–2016.Methods: A retrospective descriptive research was performed in the Clinical Universitary Hospital of Valladolid (HCUVa). Clinical data was obtained fr...

ea0073pep15.5 | Presented ePosters 15: Late Breaking | ECE2021

Pheochromocytoma secreting IL-6; an atypical presentation

Laura García María , Lisdero Ana Paula , González Pernas Mariana , Speroni Romina , Segarra Ana , Otero Jimena , Genovesi Elbio , Belli Susana , Giselle Mumbach Aizhar

Pheochromocytoma (PCC) is a rare tumor that arises from the adrenal medulla, usually presents with headache, sweating and palpitations due to excessive catecholamine release. However, PCC may secrete neuropeptides, hormones and cytokines, such as interleukin-6 (IL-6)) resulting in unusual clinical manifestations. A 48-year-old woman with a previous history of type 1 neurofibromatosis (NF1) and hypertension was referred to discarded PCC. Laboratory tests revealed leukocytosis a...